Plainsboro, NJ, United States of America

Sanjay Menon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: R&d-Biopharmaceuticals Gmbh. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay Menon. Retrieved from https://idiyas.com/inventor/sanjay-menon-bfqbiute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sanjay Menon: Innovator in Tubulysin Analogues

Introduction

Sanjay Menon is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of biopharmaceuticals, particularly through his work on tubulysin analogues. His innovative approach has led to advancements in cytostatic agents, which are crucial in cancer treatment.

Latest Patents

Sanjay Menon holds 1 patent for his invention titled "Tubulysin Analogues." This patent relates to tubulysin derivatives of general formula (II), which exhibit a cytostatic effect. His work in this area has the potential to impact therapeutic strategies in oncology.

Career Highlights

Throughout his career, Menon has worked with various organizations, including R&D Biopharmaceuticals GmbH and Dömling, Alexander. His experience in these companies has enriched his expertise in drug development and biopharmaceutical research.

Collaborations

Sanjay Menon has collaborated with notable professionals in his field, including Alexander Dömling and Bernd Henkel. These partnerships have fostered innovation and contributed to the advancement of biopharmaceuticals.

Conclusion

Sanjay Menon's contributions to the field of biopharmaceuticals, particularly through his patent on tubulysin analogues, highlight his role as an innovator. His work continues to influence the development of effective cancer treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…